Study Finds Racial Disparities in Provider-Initiated Exome Reanalysis
A decade-long study shows lower rates of provider-initiated reanalysis among Hispanic, Asian, and Black patients compared with White patients.
Latest Articles
Editor's Top Picks
Blood Test Shows Promise for Earlier ALS Detection
UCLA Health researchers find cell-free DNA combined with machine learning can distinguish ALS from other neurological conditions.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
HistoIndex to Debut FibroSIGHT Plus for Liver Fibrosis Assessment at AASLD The Liver Meeting
The CLIA-lab test marks HistoIndex’s expansion from research to routine diagnostics, offering AI-based digital pathology for quantitative liver fibrosis assessment in patients with MASH.
Equipment & Supply Spotlight
Lonza Adds Cytokines and Viral Production Medium to Cell Therapy Portfolio
New TheraPEAK products include mammalian-derived cytokines for immune cell expansion and chemically defined medium for AAV production.
News, Know-How & Standards
Disease Detection & Understanding
Can a New Blood Test Really Detect ME/CFS? An Expert Unpacks New Research
Researchers say a new blood test can diagnose ME/CFS with 96% accuracy. An expert explains what this means and how close we are to a reliable test.
